Lipoproteins are molecules made of proteins and fat. They carry cholesterol and similar substances through the blood.
A blood test can be done to measure a specific type of lipoprotein called lipoprotein-a, or Lp(a). A high level of Lp(a) is considered a risk factor for heart disease.
A blood sample is needed.
You will be asked not to eat anything for 12 hours before the test.
DO NOT smoke before the test.
A needle is inserted to draw blood. You may feel slight pain, or only a prick or stinging sensation. Afterward, there may be some throbbing.
High levels of lipoproteins can increase the risk for heart disease. The test is done to check your risk for atherosclerosis, stroke, and heart attack.
It is not yet clear if this measurement leads to improved benefits for patients. Therefore, many insurance companies DO NOT pay for it.
The American Heart Association and American College of Cardiology DO NOT recommend the test for most adults who DO NOT have symptoms. It may be useful for people at higher risk because of a strong family history of cardiovascular disease.
Normal values are below 30 mg/dL (milligrams per deciliter), or 1.7 mmol/L.
Note: Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.
The example above shows the common measurements for results of these tests. Some laboratories use different measurements or may test different specimens.
Higher than normal values of Lp(a) are associated with a high risk for atherosclerosis, stroke, and heart attack.
Lp(a) measurements may provide more detail about your risk for heart disease, but the added value of this test beyond a standard lipid panel is unknown.
Genest J, Libby P. Lipoprotein disorders and cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier; 2019:chap 48.
Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;129(25 Suppl 2):S49-S73. PMID: 24222018 pubmed.ncbi.nlm.nih.gov/24222018/.
Robinson JG. Disorders of lipid metabolism. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 195.BACK TO TOP
Review Date: 7/7/2020
Reviewed By: Thomas S. Metkus, MD, Assistant Professor of Medicine and Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2022 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.